Therapeutic use of bispecific Anti-abeta / tfr antibodies

TW202637606APending Publication Date: 2026-09-16F HOFFMANN LA ROCHE & CO AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114146871
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-09-11
Filing Date
2025-12-01
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001076581_001
    Figure TWG2TA001076581_001
  • Figure TWG2TA001076581_002
    Figure TWG2TA001076581_002
  • Figure TWG2TA001076581_003
    Figure TWG2TA001076581_003
Patent Text Reader

Abstract

antibody can be used for the treatment of a subject that is positive for amyloid plaque deposits in the brain, wherein the treatment comprises the administering of a composition comprising a therapeutically effective amount of the bispecific anti-human amyloid beta peptide / human transferrin receptor
Need to check novelty before this filing date? Find Prior Art